The writer sets a mark to look for: "...So, if you're stoked about all the news the company has posted over the last eight weeks, I get that. I can't say NexMed, Inc. is an actual 'buy', however, until the $0.55 hurdle is cleared. Conversely, a move under the floor at $0.42 is still a 'sell'. It stinks, to be sure, but this is one of those cases where a small cap stock's price is arbitrarily (and only) defined by opinion, and the opinion is always changing. There is no 'investing' in NEXM... there is only 'trading'. Follow the chart..."